Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma

Treatment resistance is observed in all advanced cancers. Colorectal cancer (CRC) presenting as colorectal adenocarcinoma (COAD) is the second leading cause of cancer deaths worldwide. Multimodality treatment includes surgery, chemotherapy, and targeted therapies with selective utilization of immuno...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kshama Gupta, Jeremy C. Jones, Virginea De Araujo Farias, Yuri Mackeyev, Pankaj K. Singh, Alfredo Quiñones-Hinojosa, Sunil Krishnan
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2022-05-01
Colección:Frontiers in Oncology
Materias:
KRAS
DDR1
BCR-ABL1
COAD
GBM
chemoradioresistance
Acceso en línea:https://www.frontiersin.org/articles/10.3389/fonc.2022.840241/full
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares